<HashMap><database>biostudies-literature</database><scores/><additional><submitter>MacMillan AC</submitter><funding>National Institutes of Health National Cancer Institute</funding><funding>BLRD VA</funding><funding>NIEHS NIH HHS</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>US Department of Veterans Affairs</funding><pagination>103649</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12166406</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>84</volume><pubmed_abstract>Myc hyperactivation coordinately regulates numerous metabolic processes to drive lymphomagenesis. Here, we elucidate the temporal and functional relationships between the medley of pathways, factors, and mechanisms that cooperate to control redox homeostasis in Myc-overexpressing B cell lymphomas. We find that Myc overexpression rapidly stimulates the oxidative pentose phosphate pathway (oxPPP), nucleotide synthesis, and mitochondrial respiration, which collectively steers cellular equilibrium to a more oxidative state. We identify Myc-dependent hyperactivation of the phosphoribosyl pyrophosphate synthetase (PRPS) enzyme as a primary regulator of redox status in lymphoma cells. Mechanistically, we show that genetic inactivation of the PRPS2 isozyme, but not PRPS1, in Myc-driven lymphoma ce</pubmed_abstract><journal>Redox biology</journal><pubmed_title>PRPS activity tunes redox homeostasis in Myc-driven lymphoma.</pubmed_title><pmcid>PMC12166406</pmcid><funding_grant_id>2I01BX001110</funding_grant_id><funding_grant_id>R25CA261610</funding_grant_id><funding_grant_id>R35 GM133561</funding_grant_id><funding_grant_id>R01CA230904</funding_grant_id><funding_grant_id>5T32ES007250-34</funding_grant_id><funding_grant_id>I01 BX001110</funding_grant_id><funding_grant_id>R01CA287260</funding_grant_id><funding_grant_id>R01 CA230904</funding_grant_id><funding_grant_id>R25 CA261610</funding_grant_id><funding_grant_id>R35GM133561</funding_grant_id><funding_grant_id>R01 CA287260</funding_grant_id><funding_grant_id>T32 ES007250</funding_grant_id><pubmed_authors>Zumwalde S</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Cunningham JT</pubmed_authors><pubmed_authors>Meller J</pubmed_authors><pubmed_authors>Czyzyk-Krzeska MF</pubmed_authors><pubmed_authors>Gertz KR</pubmed_authors><pubmed_authors>MacMillan AC</pubmed_authors><pubmed_authors>Karki B</pubmed_authors><pubmed_authors>Patel JG</pubmed_authors></additional><is_claimable>false</is_claimable><name>PRPS activity tunes redox homeostasis in Myc-driven lymphoma.</name><description>Myc hyperactivation coordinately regulates numerous metabolic processes to drive lymphomagenesis. Here, we elucidate the temporal and functional relationships between the medley of pathways, factors, and mechanisms that cooperate to control redox homeostasis in Myc-overexpressing B cell lymphomas. We find that Myc overexpression rapidly stimulates the oxidative pentose phosphate pathway (oxPPP), nucleotide synthesis, and mitochondrial respiration, which collectively steers cellular equilibrium to a more oxidative state. We identify Myc-dependent hyperactivation of the phosphoribosyl pyrophosphate synthetase (PRPS) enzyme as a primary regulator of redox status in lymphoma cells. Mechanistically, we show that genetic inactivation of the PRPS2 isozyme, but not PRPS1, in Myc-driven lymphoma ce</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-06-03T03:05:08.107Z</modification><creation>2026-04-23T03:13:25.039Z</creation></dates><accession>S-EPMC12166406</accession><cross_references><pubmed>40446642</pubmed><doi>10.1016/j.redox.2025.103649</doi></cross_references></HashMap>